STEMETIL prochlorperazine mesilate 12.5 mg/mL Injection ampoule (export)

Land: Australien

Sprog: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv bestanddel:

prochlorperazine mesilate, Quantity: 12.5 mg/mL

Tilgængelig fra:

Sanofi-Aventis Australia Pty Ltd

INN (International Name):

prochlorperazine mesilate

Lægemiddelform:

Injection

Sammensætning:

Excipient Ingredients: sodium metabisulfite; monoethanolamine; sodium sulfite; water for injections; sodium chloride

Indgivelsesvej:

Intramuscular

Enheder i pakken:

10 x 1 mL

Recept type:

(S1) This Schedule is intentionally blank

Terapeutiske indikationer:

STEMETIL is used in vertigo due to Meniere?s syndrome, labyrinthitis and other causes, and for nausea and vomiting from whatever cause. It may also be used for migraine, schizophrenia (particularly in the chronic stage), acute mania and as an adjunct to the short term management of anxiety.

Produkt oversigt:

Visual Identification: Clear solution, almost colourless or not more than very pale yellow.; Container Type: Ampoule; Container Life Time: 5 Years; Container Temperature: Store below 25 degrees Celsius

Autorisation status:

Licence status A

Autorisation dato:

2007-07-16